(whole mount) anti-rabbit IgG secondary antibody, followed by staining with DAPI. For sections, all images were captured using a standardized exposure.
Activated B cells differentiate to plasma cells to secrete IgM or, after undergoing class switch recombination (CSR), to secrete other classes of immunoglobulins [1] [2] [3] [4] . Diversification of antibody function by CSR is important for humoral immunity. However, it remains unclear how the decision for the bifurcation is made. Bach2 is a B-cell-specific transcription repressor interacting with the small Maf proteins whose expression is high only before the plasma cell stage [5] [6] [7] . Here we show that Bach2 is critical for CSR and somatic hypermutation (SHM) 2, 4, 8 of immunoglobulin genes. Genetic ablation of Bach2 in mice revealed that Bach2 was required for both T-cell-independent and T-cell-dependent IgG responses and SHM. When stimulated in vitro, Bach2-deficient B cells produced IgM, as did wild-type cells, and abundantly expressed Blimp-1 (refs 9, 10) and XBP-1 (ref. 11) , critical regulators of the plasmacytic differentiation 12 , indicating that Bach2 was not required for the plasmacytic differentiation itself. However, they failed to undergo efficient CSR. These findings define Bach2 as a key regulator of antibody response and provide an insight into the orchestration of CSR and SHM during plasma cell differentiation.
After exposure to antigen in vivo, B-cell responses may involve SHM of the variable (V)-region exons to increase the affinity of antibody, and CSR of the constant (C)-region exons of immunoglobulin heavy chain (IgH) gene to produce antibodies with the same antigen specificity performing unique effector functions [1] [2] [3] [4] 8 . Because SHM and CSR change DNA information and are therefore potentially mutagenic, their deployment must be tightly regulated. However, little is known about how transcription factors programme CSR and SHM in B cells.
Antigen-dependent terminal differentiation of B cells takes place within the secondary lymphoid organs such as spleen and lymph nodes 2, 4 . Using anti-Bach2 antibodies, we performed an immunohistochemical analysis of Bach2 in the mouse spleen. Bach2 was expressed in IgM-positive cells within the lymphoid follicles that were surrounded by marginal sinus expressing mucosal addressin cell adhesion molecule-1 (MadCAM-1 Fig. 1a ). Marginal-zone B cells, which are IgM-positive and located outside MadCAM-1-expressing cells, were negative for Bach2. Bach2 was not detected in the CD3e-positive T cells within the T-cell zone. Such an expression pattern suggests a role for Bach2 in antibody response.
To investigate this possibility, we disrupted the mouse Bach2 gene by replacing the first coding exon with a neo resistance gene cassette (Supplementary Fig. 1 (Fig. 1b, c) (Fig. 1d) . In the spleens from Bach2-deficient mice, IgM þ B cells formed follicles that were surrounded by MadCAM-1-expressing marginal sinus (Fig. 1a, and data not shown) . Thus, the formation of lymphoid follicles was obvious in the absence of Bach2. Staining with anti-Bach2 antibodies was severely diminished in the spleens from Bach2-deficient mice, verifying the specificity of the Bach2 signal in the wild-type mice (Fig. 1a) . These results indicated that Bach2 might be involved in the later stages of B-cell development, in which antigen stimulation has a crucial role.
Serum immunoglobulin concentrations were measured by isotype-specific enzyme-linked immunosorbent assay (ELISA; Fig. 2a ). The amounts of IgM in Bach2 2/2 mice were fivefold those in wildtype mice. In contrast, the mean concentrations of IgG1, IgG2a, IgG2b, IgG3 and IgA were decreased to 31%, 5%, 33%, 4% and 25%, respectively, in Bach2 2/2 mice relative to wild-type littermates. This altered pattern of serum immunoglobulin isotypes resembles that of hyper-IgM syndrome associated with immunodeficiency 13 . To examine whether Bach2 is required for antigen-dependent humoral immune responses in vivo, the Bach2 2/2 mice were immunized with T-cell-independent antigen 2,4-dinitrophenyl-conjugated Ficoll (DNP-Ficoll). The serum of Bach2 2/2 mice before immunization contained higher levels of DNP-binding IgM antibody than that of the control mice (Fig. 2b) . After immunization with DNPFicoll, DNP-binding IgM antibody increased in the wild-type mice but remained at similarly high levels in the Bach2 2/2 mice. The Bach2 þ/þ mice mounted a specific IgG3 antibody response but the Bach2 2/2 mice failed to do so (Fig. 2b) . The T-cell-dependent antibody response was examined by immunizing 4-hydroxy-3-nitrophenylacetyl-conjugated chicken g-globulin (NP-CGG). Whereas the Bach2 þ/þ mice showed a robust production of specific IgG1, the Bach2 2/2 mice failed to do so (Fig. 2c ). When immunized with sheep red blood cells (SRBC) (Fig. 2d) , specific IgM antibodies letters to nature were robustly induced, indicating that antigen-driven differentiation of IgM plasma cells was intact in the Bach2 2/2 mice. In contrast, specific IgG1 antibodies were not induced in the Bach2 2/2 mice, again indicating defects in CSR. Thus, Bach2 is essential for both T-cell-independent and T-cell-dependent production of isotype-specific antibodies. Because Bach2 2/2 B cells produced crossreacting low-affinity IgM antibodies without immunization (Fig. 2b, c) , Bach2 might be also required for normal checkpoint function of the B-cell receptor as well as for CSR.
Next we examined whether the Bach2 deficiency affects the efficiency of SHM. Mice were immunized with NP-CGG, and complementary DNA was synthesized with RNAs extracted from mesenteric lymph node to determine the sequence of the VH186.2 exon, which is well characterized as the variable region encoding anti-NP hapten 14, 15 . Nucleotide exchange mutation frequency in wild-type and Bach2 2/2 cells was 2.2 £ 10 22 per base pair (bp) (18 clones were sequenced and 114 substitutions were found in 5,238 nucleotides) and 1.2 £ 10 23 per bp (17 clones were sequenced and 6 substitutions were found in 4,947 nucleotides), respectively ( Supplementary Fig. 2a, b) . In Bach2 2/2 mice, there were few nucleotide exchanges even in complementarity-determining regions that are critical for antigen binding (Fig. 2e) . Bach2 2/2 mice failed to select the known pattern of VDJ exons for highaffinity antibodies in secondary response ( Supplementary Fig. 2c ). These results demonstrated that Bach2 is crucial for not only CSR but also for SHM.
Germinal centres (GCs) are microenvironments where antigen- (Fig. 2f) . The anatomical organization of IgM þ cells was comparable in Bach2 2/2 and in control mice after immunization (Fig. 2f) . These results indicated that Bach2 is required for GC formation.
To determine directly whether Bach2 deficiency affects CSR, we examined immunoglobulin production in vitro by treating spleen cells with lipopolysaccharide (LPS) and cytokines. The concentrations of IgG and IgA in the culture medium were significantly lower for the Bach2 2/2 cells than for the wild-type cells (Fig. 3a) . In contrast, Bach2 2/2 spleen cells showed a relatively normal level of IgM secretion in comparison with the control cells, excluding the possibility that Bach2 is required for antibody production in general. These results indicate that Bach2 is dispensable for the development of IgM plasma cells but is crucial for the development of class-switched plasma cells.
Upon the initiation of CSR, combinations of the B-cell receptor and cytokine signals determine the specificity of CSR by inducing a particular class of IgH constant-region (C H ) gene transcript (germline IgH constant-region gene transcript, GLT) [1] [2] [3] [4] . After the completion of CSR, postswitch transcript (PST) containing intervening m (Im) and each of the switched C H exons is expressed [1] [2] [3] [4] . To define letters to nature the step in CSR that requires Bach2, we examined GLT and PST in B cells stimulated with LPS and cytokines by RT-PCR. After 2 days in culture, the levels of g2b, g3 and a GLTs in the Bach2 2/2 B cells were comparable to those in the wild-type B cells (Fig. 3b) . In contrast, the quantity of g1 GLT was decreased in the Bach2 2/2 B cells. Thus, the activation of chromatin structure in the switch regions is largely unaffected by the absence of Bach2 except for g1 GLT. In contrast to GLT, PSTs were severely decreased in Bach2 2/2 B cells (Fig. 3c) . These results indicate that Bach2 deficiency caused a common defect in the cleavage and/or ligation of the switch regions. Because cell proliferation is a prerequisite for CSR 16 , proliferation activities of Bach2 2/2 B cells were assessed by measuring BrdU incorporation by B220 þ B cells that were purified from spleen. Responses to LPS, which was used to induce plasma cells in the above experiments, were indistinguishable between Bach2 2/2 and wild-type spleen B cells (Supplementary Fig. 3 ).
Bach2 might regulate the expression of genes involved in CSR and SHM. This possibility was investigated by comparing the expression of activation-induced cytidine deaminase (AID), which is necessary for both SHM and CSR 17 . Using purified B220 þ spleen B cells stimulated with LPS, quantitative polymerase chain reaction with reverse transcription (RT-PCR) revealed that the expression of AID was reduced to 0.12% in the Bach2 2/2 B cells after 2 days of treatment with LPS (Fig. 3d) . Considering its well-characterized crucial role in SHM and CSR, we next investigated whether the reduced expression of AID caused the CSR defects of Bach2 2/2 B cells by retroviral complementation. letters to nature Bach1 (refs 6, 25, 26) might partly replace Bach2 because it is expressed in B cells (Fig. 3d) . The differentiation of plasma cells poses a general question about lineage choice in haematopoietic cells in that CSR, which is not reversible, is selected only in a subset of plasma cells. Studies on lineage choice have indicated that transcription factors might programme individual lineages. We have shown here that antibody responses involving CSR, SHM and GC formation were severely impaired in Bach2-deficient mice (Fig. 4b) . In addition, Bach2 2/2 B cells can differentiate to IgM-secreting plasma cells. In this regard, Bach2 stands in contrast with known plasma-cell transcription factors such as Blimp-1 and XBP-1, which are necessary for both non-IgM and IgM plasma cells 10, 11 . Our observations demonstrate that Bach2 is a hitherto unknown regulator of antibody response. Understanding the direct target genes of Bach2 as well as the signalling cascades that regulate the activity of Bach2 in B cells could reveal a novel molecular link between B-cell activation and antibody response.
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Immunofluorescence staining
Frozen sections of spleen were stained with antibodies: FITC-conjugated anti-mouse IgM, biotin-conjugated anti-mouse IgM, biotin-conjugated anti-mouse CD3e (145-2C11) and purified anti-mouse MadCAM-1 (MECA-367) (BD Pharmingen), and with FITCconjugated PNA (HONEN). Cy3-conjugated goat anti-rat IgG (Rockland), Alexa Fluor 488 goat anti-rabbit IgG (Molecular Probes) and Cy3-conjugated avidin were used as secondary antibodies. Image acquisition was as described previously 27 .
Disruption of the Bach2 gene
Analysis of genomic phage clones of mouse Bach2 was as described previously 28 ; detailed information is available from the authors on request. The Bach2-targeting vector (pB2TV) was constructed by using DNA fragments containing the b-galactosidase (lacZ) gene with SV40 polyadenylation (poly(A)) signal derived from pCMVb vector (Clontech) and the neomycin resistance (neo) gene driven by the phosphoglycerate kinase (PGK)-1 promoter (PGK-neo), which was flanked by a loxP sequence on both sides. These cassettes were cloned between short-arm and long-arm DNA. The 3.0-kb short-arm DNA was isolated from the genomic phage clone by PCR with a Bach2-specific primer and a primer for the vector sequence. The Bach2-specific primer possessed an EcoRI site at the 5 0 end (B2SARev  primer 5 0 -AATTAAgaattcGTTCAAACCCTGGAATAAAGAG-3 0 ) and the PCR product was cloned as an EcoRI DNA. The 6.7-kb long-arm DNA covered between the EcoRI site and the 3 0 end of the phage clone end. A cDNA containing diphteria toxin A driven by the PGK promoter (PGK-DTA), without a poly(A) signal, was then subcloned beyond the short arm to complete the construct (see Supplementary Fig. 1a) . The pB2TV was linearized with NotI. The linearized targeting vector was transfected into embryonic stem cell line E14. Appropriately targeted embryonic stem cell clones ( Supplementary Fig. 1b ) were used to obtain chimaeric mice that transmitted the disrupted locus through the germ line. Two independent embryonic stem clones gave rise to Bach2 2/2 mouse lines with the same phenotype. The 4-12-week-old mice used in this study were backcrossed to the C57BL/6J background for one or two generations; wild-type littermates were used as controls. Immunoblotting of bone marrow extracts with anti-Bach2 antibody detected Bach2 in the wild-type mice but not in Bach2 2/2 mice ( Supplementary Fig. 1c ).
Fluorescence-activated cell sorting (FACS) analysis
FACS analysis was performed with antibodies against mouse CD45R/B220, CD43 (S7), IgM (R6-60.2), IgD, IgG1, IgG3, TER-119, Ly-6G/Gr-1, CD11b/Mac-1, CD4, CD8, CD21 and CD23 (BD Pharmingen). The cells were analysed on a FACScalibur with CellQuest software (Becton Dickinson).
Determination of immunoglobulin levels
Immunoglobulin concentrations were determined with a standard procedure by using antibodies specific for each mouse immunoglobulin isotype and with p-nitrophenylphosphate as a substrate for the alkaline phosphatase-conjugated secondary antibodies (Clonotyping System/AP; Southern Biotechnology Associates).
In vivo immunizations and SHM assay
Mice (7-12 weeks old, four mice for each genotype) were immunized intraperitoneally with 100 mg of DNP-Ficoll (Biosearch Technologies) in PBS (Nissui), 100 mg NP-chicken gamma-globulin (NP-CGG; Biosearch Technologies) mixed with alum, or 10 8 cells of SRBC. Levels of anti-DNP, anti-NP and anti-SRBC antibodies were determined by ELISA with DNP-BSA, NP-BSA (Biosearch Technologies) and soluble SRBC, respectively, as capture agents. Somatic hypermutation assay was performed as described previously 17 .
In vitro class switching assay RBC-depleted splenocytes (10 5 ) were cultured in 96-well plates in a total volume of 200 ml RPMI medium. The cells were treated with 20 mg ml 21 LPS (0111:B4; Sigma), 10 ng ml 21 recombinant mouse interleukin-4 (BD Pharmingen) and 1 ng ml 21 recombinant human TGF-b1 (R&D Systems) in indicated combinations. Proliferation of spleen B cells (B220 þ magnetic bead selection; Miltenyi Biotech) were measured by using cell-proliferation ELISA (BrdU kit; Roche).
RT-PCR
RNA preparation and cDNA synthesis were as described previously 7 . Sequences of PCR primers are available from the authors on request. For quantitative TaqMan RT-PCR (AID, Blimp-1, BCL-6, Pax5, XBP-1 and hypoxanthine guanine phosphoribosyl transferase (HPRT)), cDNA samples were analysed in triplicate with a TaqMan universal PCR master kit and an ABI 7700 sequence detection system with primers and probes from Assays-on-Demand gene expression products (Applied Biosystems). For quantitative RT-PCR (OCA-B and HPRT), cDNA samples were analysed with a LightCycler FastStart DNA master SYBR Green I kit and a LightCycler system (Roche).
Retroviral infection
Preparation of retrovirus was as described previously 27 . Purified B220 þ spleen B cells were preactivated with 20 mg ml 21 LPS and 10 ng ml 21 interleukin-4 for 2 days before infection. Preactivated cells were suspended at a density of 5 £ 10 5 cells ml 21 in the medium containing retrovirus supplemented with 16 mg ml 21 Polybrene, centrifuged at 927g for 90 min at 32 8C and incubated for 48 h. The cells were then washed and incubated for 24 h. To analyse the expression of surface IgG1 and IgG3 by FACS, live cells were gated on the basis of cell size and staining by propidium iodide.
